跳到正文
原文
Medical Xpress·· 2026-10-16AI 评分48

AI 有望帮助预测哪些 HPV 感染会进展为癌症

AI could help predict which HPV infections progress to cancer

AI 导读

比利时列日大学团队在《Trends in Molecular Medicine》发文提出,AI 整合多组学数据有望帮助预测 HPV 感染是否会进展为癌症,但模型尚未充分验证用于临床。研究人员认为单一生物标志物预测感染结局已达极限,未来或有助于个性化风险管理和减少不必要的干预。

正文
MH
Credit: IA - ChatGPT

For several decades, researchers have sought to identify biomarkers capable of accurately predicting the outcome of an infection with a high-risk oncogenic HPV type. Despite significant advances, no viral, immune-related or molecular marker can currently and reliably predict which infections will regress spontaneously and which will progress to more severe disease.

This difficulty stems from the complex and dynamic nature of HPV-associated carcinogenesis (the biological process by which a healthy cell becomes a cancer cell). The outcome of an infection is shaped by numerous factors, including viral characteristics, the host immune response, genetic and epigenetic factors, the microbiome, hormonal influences and environmental exposures. These interactions are further complicated by random biological events, including the accumulation of mutations associated with virus-induced genomic instability.

"The main challenge may no longer be to discover a new biomarker, but rather to understand how all these biological mechanisms interact to determine the outcome of an HPV infection," explains Michael Herfs, an oncologist at GIGA (University of Liège).

The paper is published in the journal Trends in Molecular Medicine.

Artificial intelligence as a new source of hope

Faced with this complexity, Diane Bruyère, Romane Geuzaine and Herfs believe that approaches based on a single biomarker have probably reached their limits. Recent advances in high-throughput molecular profiling and artificial intelligence are now opening up new perspectives.

These technologies make it possible to integrate large amounts of biological data simultaneously to build more comprehensive predictive models. The objective is to better distinguish between the possible trajectories of an HPV infection or a low-grade precancerous lesion: spontaneous regression, persistence or progression to a more severe lesion, including invasive cancer. These integrative approaches are currently considered among the most promising avenues for improving risk stratification.

"Artificial intelligence and integrative models could help us better understand the diversity of biological trajectories observed among patients and, ultimately, provide a more personalized assessment of risk," says Bruyère.

Toward more personalized patient management

Although these new models generate considerable hope, they have not yet been sufficiently validated for routine clinical use. Today, patient management still relies on HPV testing, cytology and histopathological assessment, combined with relatively nonindividualized follow-up.

According to the researchers, the future lies in developing a broader understanding of the biology of HPV infections rather than in the search for a single predictive marker. Ultimately, more accurate individual risk assessment could make it possible to tailor patient follow-up, reduce unnecessary interventions and improve the management of people with HPV infections.

Publication details

Diane Bruyere et al., Predicting outcomes in oncogenic HPV infection: are we there yet?, Trends in Molecular Medicine (2026). DOI: 10.1016/j.molmed.2026.09.009

Journal information: Trends in Molecular Medicine

Who's behind this story?

Gaby Clark

Gaby Clark

MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →

Alexander Pol

Alexander Pol

PhD nano-engineering from Delft University. Published researcher and journal reviewer. Brings scientific insight to content standards. Full profile →

Citation: AI could help predict which HPV infections progress to cancer (2026, October 15) retrieved 15 October 2026 from https://medicalxpress.com/news/2026-10-ai-hpv-infections-cancer.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com